Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Toremifene vs Tamoxifen in Premenopausal Breast Cancer
NCT02344940Phase 4Completed
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- Dec 2014
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of toremifene in breast cancer (2 arms), sponsored by Shanghai Jiao Tong University School of Medicine. Primary endpoint: Incidence of ovarian cyst at 1 year. Started Dec 2014; status: completed.
02
Drugs
toremifene
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02344940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02344940.